NIH invests in next iteration of public-private partnership to advance precision medicine research for Alzheimer’s disease
The National Institutes of Health has launched the next version of the Accelerating Medicines Partnership (AMP) Alzheimer’s disease program (AMP AD 2.0) to expand the open science, big data approach for identifying biological targets for therapeutic intervention.